SCHEMBL30629324

SCHEMBL30629324

Cc1nc(Cl)nc(C(=O)O)c1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 3/20 0.44
TDP1 Q9NUW8 2/20 0.44
ALDH1A1 P00352 3/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.34
MAPK1 P28482 1/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
PKM P14618 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
PIN1 Q13526 2/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
POLB P06746 2/20 0.32
KDM4E B2RXH2 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1026100 0.83 ALDH1A1 (0.39) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL28196712 0.77 TDP1 (0.57) HCAR2TDP1ALDH1A1TSHRSMN1; SMN2
SCHEMBL6169849 0.76 MEN1 (0.53) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL31295775 0.76 ALDH1A1 (0.38) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL21887822 0.75 TDP1 (0.66) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL27029927 0.75 KDM5B (0.46) ALDH1A1MAPK1PKML3MBTL1HSD17B10
SCHEMBL3543372 0.75 ALDH1A1 (0.47) HCAR2ALDH1A1HPGDTSHRSMN1; SMN2
SCHEMBL30151422 0.74 TDP1 (0.53) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL1919221 0.74 HCAR2 (0.39) HCAR2TDP1ALDH1A1HPGDTSHR
SCHEMBL28149647 0.74 TDP1 (0.53) HCAR2TDP1ALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655688-B Substituted pyrrolopyridines as ATR inhibitors 蓝谷制药有限责任公司 2023-09-29 CN disclosed